20 June 2013
Keywords: sanofi, initiates, ph, ii, trial, melanoma, vacc
Article | 29 September 2008
Sanofi Pasteur, the vaccines division of French drug major Sanofi-Aventis, is sponsoring a Phase II study exploring a multi-pronged
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 September 2008
19 June 2013
© 2013 thepharmaletter.com